New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Schott Lands $1B Deal for Glass Cartridges and Syringes

Schott Pharma locked in $1 billion worth of contracts to supply essential components for diabetes and weight-loss drugs.

Screen Shot 2022 04 18 At 2 39 39 Pm
Getty Images

A recent Yahoo! Finance article discussed the latest 10-figure deal in pharmaceutical packaging. Germany's Schott Pharma has secured contracts worth approximately $1 billion to supply glass cartridges and syringes to leading companies in the GLP-1 drug class, catering to diabetes and weight-loss drugs. Schott’s CEO, Andreas Reisse, announced these contracts during the company's IPO launch event, highlighting the significance of GLP-1 drugs in the pharmaceutical industry. 

While the customer names remain confidential, the long-term contracts cover various components, including packaging for the injectable GLP-1 drugs. The GLP-1 drug class is gaining steam, with Novo Nordisk's Wegovy being a notable product that has driven high market demand and contributed to Novo's status as Europe's most valuable listed company.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts